Compass Therapeutics, Inc.

CMPX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13D/A Jul 14, 2021 AMENDMENT NO. 1
S-3 Jul 9, 2021 S-3
8-K Jun 30, 2021 8-K
4 Jun 29, 2021 PRIMARY DOCUMENT
3 Jun 29, 2021 PRIMARY DOCUMENT
8-K Jun 4, 2021 8-K
8-K May 13, 2021 8-K
4 May 5, 2021 FORM 4 SUBMISSION
3 May 5, 2021 FORM 3 SUBMISSION
424B3 Apr 30, 2021 424B3
10-Q Apr 30, 2021 10-Q
DEF 14A Apr 29, 2021 DEF 14A
8-K Apr 19, 2021 8-K
424B3 Mar 11, 2021 424B3
EFFECT Mar 8, 2021
POS AM Mar 5, 2021 POS AM
10-K Mar 5, 2021 10-K
4 Mar 1, 2021 FORM 4 SUBMISSION
4 Mar 1, 2021 FORM 4 SUBMISSION
SC 13G/A Feb 8, 2021
S-8 Jan 14, 2021 FORM S-8
4 Dec 23, 2020 FORM 4 SUBMISSION
8-K Dec 17, 2020 8-K
RW Nov 13, 2020 REGISTRATION WITHDRAWAL
CERT Nov 12, 2020 8A CERT
← Newer Page 12 of 15 · 359 filings Older →